DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Wei A, Strickland S, Roboz G. et al.
Safety and efficacy of venetoclax plus low-dose cytarabine in treatment-naive patients aged ≥65 years with acute myeloid leukemia. Proceedings from the 2016 annual meeting of the American Society of Hematology (ASH).

Blood 2016;
128: Abstract 102

Download Bibliographical Data

Search in: